These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 10339292)

  • 1. Fasting insulin and apolipoprotein B levels and low density lipoprotein particle size as risk factors for ischemic heart disease.
    Moore M
    J Insur Med; 1998; 30(2):111-2. PubMed ID: 10339292
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies of LDL particle size and susceptibility to oxidation and association with glucose metabolism in children after heart transplantation.
    Siirtola A; Antikainen M; Ala-Houhala M; Solakivi T; Jokela H; Lehtimäki T; Holmberg C; Salo MK
    J Heart Lung Transplant; 2004 Apr; 23(4):418-26. PubMed ID: 15063401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High insulin levels and increased low-density lipoprotein oxidizability in pediatric patients with systemic lupus erythematosus.
    Posadas-Romero C; Torres-Tamayo M; Zamora-González J; Aguilar-Herrera BE; Posadas-Sánchez R; Cardoso-Saldaña G; Ladrón de Guevara G; Solis-Vallejo E; El Hafidi M
    Arthritis Rheum; 2004 Jan; 50(1):160-5. PubMed ID: 14730612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective, population-based study of low density lipoprotein particle size as a risk factor for ischemic heart disease in men.
    Lamarche B; St-Pierre AC; Ruel IL; Cantin B; Dagenais GR; Després JP
    Can J Cardiol; 2001 Aug; 17(8):859-65. PubMed ID: 11521128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving prediction of ischemic cardiovascular disease in the general population using apolipoprotein B: the Copenhagen City Heart Study.
    Benn M; Nordestgaard BG; Jensen GB; Tybjaerg-Hansen A
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):661-70. PubMed ID: 17170368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond low-density lipoprotein cholesterol: defining the role of low-density lipoprotein heterogeneity in coronary artery disease.
    Mudd JO; Borlaug BA; Johnston PV; Kral BG; Rouf R; Blumenthal RS; Kwiterovich PO
    J Am Coll Cardiol; 2007 Oct; 50(18):1735-41. PubMed ID: 17964036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes of blood lipids and apolipoproteins in patients with silent myocardial ischemia].
    Tan M; Zhao S; Yu S
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(1):44-6, 56. PubMed ID: 10681793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flaxseed on cardiovascular disease markers in healthy menopausal women: a randomized, double-blind, placebo-controlled trial.
    Dodin S; Cunnane SC; Mâsse B; Lemay A; Jacques H; Asselin G; Tremblay-Mercier J; Marc I; Lamarche B; Légaré F; Forest JC
    Nutrition; 2008 Jan; 24(1):23-30. PubMed ID: 17981439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inter-relationships between small, dense low-density lipoprotein (LDL), plasma triacylglycerol and LDL apoprotein B in an atherogenic lipoprotein phenotype in free-living subjects.
    Griffin BA; Minihane AM; Furlonger N; Chapman C; Murphy M; Williams D; Wright JJ; Williams CM
    Clin Sci (Lond); 1999 Sep; 97(3):269-76. PubMed ID: 10464051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-density lipoprotein, non-high-density lipoprotein, and apolipoprotein B as targets of lipid-lowering therapy.
    Feeman WE
    Circulation; 2003 May; 107(20):e199. PubMed ID: 12777330
    [No Abstract]   [Full Text] [Related]  

  • 11. Subclasses of low-density lipoprotein and very low-density lipoprotein in familial combined hyperlipidemia: relationship to multiple lipoprotein phenotype.
    Georgieva AM; van Greevenbroek MM; Krauss RM; Brouwers MC; Vermeulen VM; Robertus-Teunissen MG; van der Kallen CJ; de Bruin TW
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):744-9. PubMed ID: 14751815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of short- and long-term growth hormone replacement on lipoprotein composition and on very-low-density lipoprotein and low-density lipoprotein apolipoprotein B100 kinetics in growth hormone-deficient hypopituitary subjects.
    Kearney T; de Gallegos CN; Proudler A; Parker K; Anayaoku V; Bannister P; Venkatesan S; Johnston DG
    Metabolism; 2003 Jan; 52(1):50-9. PubMed ID: 12524662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does low-density lipoprotein size add to atherogenic particle number in predicting the risk of fatal myocardial infarction?
    Jungner I; Sniderman AD; Furberg C; Aastveit AH; Holme I; Walldius G
    Am J Cardiol; 2006 Apr; 97(7):943-6. PubMed ID: 16563891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of prolonged fasting on plasma lipids, lipoproteins and apolipoprotein B in 12 physicians participating in a hunger strike: an observational study.
    Fainaru M; Schafer Z
    Isr Med Assoc J; 2000 Mar; 2(3):215-9. PubMed ID: 10774270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
    Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-density lipoprotein particle size, insulin resistance, and proinsulin in a population sample of 58-year-old men.
    Fagerberg B; Hulthe J; Bokemark L; Wikstrand J
    Metabolism; 2001 Jan; 50(1):120-4. PubMed ID: 11172485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postprandial changes in LDL phenotypes in patients with myocardial infarction.
    Koba S; Tsunoda F; Hirano T; Iso Y; Suzuki H; Geshi E; Katagiri T
    Eur J Clin Invest; 2005 Mar; 35(3):171-9. PubMed ID: 15733071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of short-term modest weight loss on fasting and post-prandial lipoprotein sub-fractions in type 2 diabetes mellitus patients.
    Ybarra J; James RW; Makoundou V; Bioletto S; Golay A
    Diabetes Metab; 2001 Dec; 27(6):701-8. PubMed ID: 11852380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of small dense low-density lipoprotein in coronary artery disease patients with normal plasma cholesterol levels].
    Koba S; Hirano T; Sakaue T; Sakai K; Kondo T; Yorozuya M; Suzuki H; Murakami M; Katagiri T
    J Cardiol; 2000 Dec; 36(6):371-8. PubMed ID: 11190580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships between serum levels of autoantibodies against oxidized low density lipoproteins, lipid-soluble antioxidants and apolipoprotein B in patients with coronary heart disease.
    Bakalova RA; Hadzhimitova V; Ribarov S
    Gen Physiol Biophys; 2000 Mar; 19(1):103-13. PubMed ID: 10930142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.